Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of skin physiology (HP:0011122)help
Grandparent Node:
expand
Increased inflammatory response (HP:0012649)help
Parent Node:
expand
Inflammatory abnormality of the skin (HP:0011123)help
..Starting node
..expand
Acne (HP:0001061)help
Term ID: 1061
Name: Acne
Synonym: Acne; Breaking out
Definition: A skin condition in which there is an increase in sebum secretion by the pilosebaceous apparatus associated with open comedones (blackheads), closed comedones (whiteheads), and pustular nodules (papules, pustules, and cysts).
Comments:
Reference: HP:0001061
Genes and Diseases:
 
       Child Nodes:
........expandComedonal acne (HP:0040137) help
........expandAcne inversa (HP:0040154) help

 Sister Nodes: 
..expandAtopic dermatitis (HP:0001047) help
..expandCrusting erythematous dermatitis (HP:0007473) help
..expandCutaneous abscess (HP:0031292) help
..expandDeep dermal perivascular inflammatory infiltrate (HP:0031191) help
..expandEczema (HP:0000964) help
..expandErysipelas (HP:0001055) help
..expandErythema nodosum (HP:0012219) help
..expandErythroderma (HP:0001019) help
..expandFolliculitis (HP:0025084) help
..expandNeutrophilic infiltration of the skin (HP:0031234) help
..expandPerifolliculitis (HP:0012322) help
..expandPsoriasiform dermatitis (HP:0003765) help
..expandPustule (HP:0200039) help
..expandRecurrent skin infections (HP:0001581) help
..expandSkin rash (HP:0000988) help
..expandSuperficial dermal perivascular inflammatory infiltrate (HP:0031190) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0001061HP:0001061Acne0ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional415
HP:0001061HP:0001061Acne0AGA CL E G H175318OMIM:208400ASPARTYLGLUCOSAMINURIA.76
HP:0001061HP:0001061Acne0AIP CL E G H9049358ORPHA:963AcromegalyHP:0040283 - Occasional95
HP:0001061HP:0001061Acne0AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040284 - Very rare125
HP:0001061HP:0001061Acne0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0001061HP:0001061Acne0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent1
HP:0001061HP:0001061Acne0ATRX CL E G H546886ORPHA:96253Cushing diseaseHP:0040282 - Frequent169
HP:0001061HP:0001061Acne0BRAF CL E G H6731097ORPHA:96253Cushing diseaseHP:0040282 - Frequent276
HP:0001061HP:0001061Acne0C4A CL E G H7201323ORPHA:117Behçet diseaseHP:0040282 - Frequent1
HP:0001061HP:0001061Acne0CCR1 CL E G H12301602ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001061HP:0001061Acne0CDH23 CL E G H6407213733ORPHA:96253Cushing diseaseHP:0040282 - Frequent636
HP:0001061HP:0001061Acne0CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0001061HP:0001061Acne0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent6
HP:0001061HP:0001061Acne0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040282 - Frequent112
HP:0001061HP:0001061Acne0ECM1 CL E G H18933153ORPHA:530Lipoid proteinosisHP:0040281 - Very frequent14
HP:0001061HP:0001061Acne0ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional151
HP:0001061HP:0001061Acne0ERAP1 CL E G H5175218173ORPHA:117Behçet diseaseHP:0040282 - Frequent1
HP:0001061HP:0001061Acne0ESR1 CL E G H20993467OMIM:615363Estrogen resistance.13
HP:0001061HP:0001061Acne0ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndromeHP:0040282 - Frequent13
HP:0001061HP:0001061Acne0FAS CL E G H35511920ORPHA:117Behçet diseaseHP:0040282 - Frequent59
HP:0001061HP:0001061Acne0FGFR2 CL E G H22633689OMIM:101200Apert syndrome.175
HP:0001061HP:0001061Acne0GJB2 CL E G H27064284ORPHA:477KID syndrome199
HP:0001061HP:0001061Acne0GJB6 CL E G H108044288ORPHA:477KID syndrome56
HP:0001061HP:0001061Acne0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0001061HP:0001061Acne0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent8
HP:0001061HP:0001061Acne0GPR101 CL E G H8355014963ORPHA:963AcromegalyHP:0040283 - Occasional5
HP:0001061HP:0001061Acne0H6PD CL E G H95634795OMIM:604931Cortisone reductase deficiency 1.8
HP:0001061HP:0001061Acne0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent3
HP:0001061HP:0001061Acne0HLA-B CL E G H31064932ORPHA:117Behçet diseaseHP:0040282 - Frequent4
HP:0001061HP:0001061Acne0HPGD CL E G H32485154ORPHA:2796PachydermoperiostosisHP:0040282 - Frequent55
HP:0001061HP:0001061Acne0HYOU1 CL E G H1052516931OMIM:233600Immunodeficiency 59 and hypoglycemia
HP:0001061HP:0001061Acne0IFNGR1 CL E G H34595439ORPHA:117Behçet diseaseHP:0040282 - Frequent60
HP:0001061HP:0001061Acne0IKBKB CL E G H35515960OMIM:618204IMMUNODEFICIENCY 15A; IMD15A4
HP:0001061HP:0001061Acne0IL10 CL E G H35865962ORPHA:117Behçet diseaseHP:0040282 - Frequent2
HP:0001061HP:0001061Acne0IL12A CL E G H35925969ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001061HP:0001061Acne0IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001061HP:0001061Acne0IL23R CL E G H14923319100ORPHA:117Behçet diseaseHP:0040282 - Frequent1
HP:0001061HP:0001061Acne0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent2
HP:0001061HP:0001061Acne0KDF1 CL E G H12669526624OMIM:617337Ectodermal dysplasia 12, Hypohidrotic/hair/tooth/nail type1
HP:0001061HP:0001061Acne0KLRC4 CL E G H83026377ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001061HP:0001061Acne0KRT5 CL E G H38526442ORPHA:79145Dowling-Degos disease173
HP:0001061HP:0001061Acne0LHCGR CL E G H39736585ORPHA:3000Familial male-limited precocious pubertyHP:0040282 - Frequent67
HP:0001061HP:0001061Acne0LPIN2 CL E G H966314450ORPHA:77297Majeed syndromeHP:0040282 - Frequent186
HP:0001061HP:0001061Acne0MEFV CL E G H42106998ORPHA:117Behçet diseaseHP:0040282 - Frequent281
HP:0001061HP:0001061Acne0MEFV CL E G H42106998OMIM:608068NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE281
HP:0001061HP:0001061Acne0MEFV CL E G H42106998ORPHA:3243Sweet syndromeHP:0040282 - Frequent281
HP:0001061HP:0001061Acne0MEIS2 CL E G H42127001ORPHA:26119015q14 microdeletion syndromeHP:0040283 - Occasional7
HP:0001061HP:0001061Acne0NCSTN CL E G H2338517091OMIM:142690Acne inversa, familial5
HP:0001061HP:0001061Acne0NR3C1 CL E G H29087978ORPHA:96253Cushing diseaseHP:0040282 - Frequent79
HP:0001061HP:0001061Acne0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040282 - Frequent79
HP:0001061HP:0001061Acne0PAPSS2 CL E G H90608604OMIM:612847Brachyolmia 4 with mild epiphyseal and metaphyseal changes.20
HP:0001061HP:0001061Acne0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0001061HP:0001061Acne0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0001061HP:0001061Acne0POFUT1 CL E G H2350914988ORPHA:79145Dowling-Degos disease2
HP:0001061HP:0001061Acne0POGLUT1 CL E G H5698322954ORPHA:79145Dowling-Degos disease6
HP:0001061HP:0001061Acne0PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0001061HP:0001061Acne0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0001061HP:0001061Acne0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0001061HP:0001061Acne0PSEN1 CL E G H56639508OMIM:613737Acne inversa, familial, 3241
HP:0001061HP:0001061Acne0PSENEN CL E G H5585130100OMIM:613736Acne inversa, familial, 2, with or without dowling-degos disease2
HP:0001061HP:0001061Acne0PSENEN CL E G H5585130100ORPHA:79145Dowling-Degos disease2
HP:0001061HP:0001061Acne0PSTPIP1 CL E G H90519580ORPHA:69126Pyogenic arthritis-pyoderma gangrenosum-acne syndromeHP:0040281 - Very frequent96
HP:0001061HP:0001061Acne0PSTPIP1 CL E G H90519580OMIM:604416Pyogenic sterile arthritis, pyoderma gangrenosum, and acne96
HP:0001061HP:0001061Acne0RBP4 CL E G H59509922OMIM:615147Retinal dystrophy, iris coloboma, and comedogenic acne syndrome8
HP:0001061HP:0001061Acne0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0001061HP:0001061Acne0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0001061HP:0001061Acne0SH3PXD2B CL E G H28559029242ORPHA:137834Frank-Ter Haar syndromeHP:0040281 - Very frequent134
HP:0001061HP:0001061Acne0SH3PXD2B CL E G H28559029242OMIM:249420Frank-ter Haar syndrome.134
HP:0001061HP:0001061Acne0SLCO2A1 CL E G H657810955OMIM:167100Hypertrophic osteoarthropathy, primary, autosomal dominant13
HP:0001061HP:0001061Acne0SLCO2A1 CL E G H657810955OMIM:614441Hypertrophic osteoarthropathy, primary, autosomal recessive 213
HP:0001061HP:0001061Acne0SLCO2A1 CL E G H657810955ORPHA:2796PachydermoperiostosisHP:0040282 - Frequent13
HP:0001061HP:0001061Acne0STAT4 CL E G H677511365ORPHA:117Behçet diseaseHP:0040282 - Frequent2
HP:0001061HP:0001061Acne0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent32
HP:0001061HP:0001061Acne0TBX1 CL E G H689911592OMIM:188400Digeorge syndrome32
HP:0001061HP:0001061Acne0TLR4 CL E G H709911850ORPHA:117Behçet diseaseHP:0040282 - Frequent3
HP:0001061HP:0001061Acne0TP53 CL E G H715711998ORPHA:96253Cushing diseaseHP:0040282 - Frequent911
HP:0001061HP:0001061Acne0UBAC2 CL E G H33786720486ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001061HP:0001061Acne0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0001061HP:0001061Acne0USP48 CL E G H8419618533ORPHA:96253Cushing diseaseHP:0040282 - Frequent1
HP:0001061HP:0001061Acne0USP8 CL E G H910112631ORPHA:96253Cushing diseaseHP:0040282 - Frequent7
HP:0001061HP:0001061Acne0WNT4 CL E G H5436112783ORPHA:247768Müllerian aplasia and hyperandrogenismHP:0040281 - Very frequent4
HP:0001061HP:0001061Acne0WNT4 CL E G H5436112783OMIM:158330Mullerian aplasia and hyperandrogenismHP:0040282 - Frequent4
HP:0001061HP:0001061Acne0XIAP CL E G H331592OMIM:300635Lymphoproliferative syndrome, X-linked, 2.81
HP:0001061HP:0001061Acne0XYLT1 CL E G H6413115516ORPHA:370930XYLT1-CDGHP:0040282 - Frequent14
HP:0001061HP:0040154Acne inversa1GJB2 CL E G H27064284ORPHA:477KID syndrome199
HP:0001061HP:0040154Acne inversa1GJB6 CL E G H108044288ORPHA:477KID syndrome56
HP:0001061HP:0040154Acne inversa1HYOU1 CL E G H1052516931OMIM:233600Immunodeficiency 59 and hypoglycemia.
HP:0001061HP:0040154Acne inversa1IKBKB CL E G H35515960OMIM:618204IMMUNODEFICIENCY 15A; IMD15A4
HP:0001061HP:0040154Acne inversa1KDF1 CL E G H12669526624OMIM:617337Ectodermal dysplasia 12, Hypohidrotic/hair/tooth/nail type.1
HP:0001061HP:0040154Acne inversa1KRT5 CL E G H38526442ORPHA:79145Dowling-Degos diseaseHP:0040283 - Occasional173
HP:0001061HP:0033188Cystic acne1MEFV CL E G H42106998OMIM:608068NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE281
HP:0001061HP:0040154Acne inversa1MEFV CL E G H42106998OMIM:608068NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE281
HP:0001061HP:0040154Acne inversa1MEFV CL E G H42106998ORPHA:3243Sweet syndromeHP:0040283 - Occasional281
HP:0001061HP:0040154Acne inversa1NCSTN CL E G H2338517091OMIM:142690Acne inversa, familial.5
HP:0001061HP:0040154Acne inversa1POFUT1 CL E G H2350914988ORPHA:79145Dowling-Degos diseaseHP:0040283 - Occasional2
HP:0001061HP:0040154Acne inversa1POGLUT1 CL E G H5698322954ORPHA:79145Dowling-Degos diseaseHP:0040283 - Occasional6
HP:0001061HP:0040154Acne inversa1PSEN1 CL E G H56639508OMIM:613737Acne inversa, familial, 3241
HP:0001061HP:0040154Acne inversa1PSENEN CL E G H5585130100OMIM:613736Acne inversa, familial, 2, with or without dowling-degos disease.2
HP:0001061HP:0040154Acne inversa1PSENEN CL E G H5585130100ORPHA:79145Dowling-Degos diseaseHP:0040283 - Occasional2
HP:0001061HP:0033188Cystic acne1PSTPIP1 CL E G H90519580OMIM:604416Pyogenic sterile arthritis, pyoderma gangrenosum, and acne96
HP:0001061HP:0040137Comedonal acne1RBP4 CL E G H59509922OMIM:615147Retinal dystrophy, iris coloboma, and comedogenic acne syndrome.8


Genes (72) :ABCC6 AGA AIP AR ARMC5 ARVCF ATRX BRAF C4A CCR1 CDH23 CLN3 COMT CYP11B1 ECM1 ENPP1 ERAP1 ESR1 FAS FGFR2 GJB2 GJB6 GNAS GP1BB GPR101 H6PD HIRA HLA-B HPGD HYOU1 IFNGR1 IKBKB IL10 IL12A IL12A-AS1 IL23R JMJD1C KDF1 KLRC4 KRT5 LHCGR LPIN2 MEFV MEIS2 NCSTN NR3C1 PAPSS2 PDE11A PDE8B POFUT1 POGLUT1 PRKACA PRKAR1A PSEN1 PSENEN PSTPIP1 RBP4 RREB1 SEC24C SH3PXD2B SLCO2A1 STAT4 TBX1 TLR4 TP53 UBAC2 UFD1 USP48 USP8 WNT4 XIAP XYLT1

Diseases (45) :ORPHA:758 OMIM:208400 ORPHA:963 ORPHA:99429 ORPHA:189427 ORPHA:567 ORPHA:96253 ORPHA:117 ORPHA:228346 ORPHA:90795 ORPHA:530 OMIM:615363 ORPHA:785 OMIM:101200 ORPHA:477 OMIM:604931 ORPHA:2796 OMIM:233600 OMIM:618204 OMIM:617337 ORPHA:79145 ORPHA:3000 ORPHA:77297 OMIM:608068 ORPHA:3243 ORPHA:261190 OMIM:142690 ORPHA:786 OMIM:612847 ORPHA:189439 OMIM:615830 OMIM:613737 OMIM:613736 ORPHA:69126 OMIM:604416 OMIM:615147 ORPHA:137834 OMIM:249420 OMIM:167100 OMIM:614441 OMIM:188400 ORPHA:247768 OMIM:158330 OMIM:300635 ORPHA:370930
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.